1-9 of 9
Tommaso Caravita Di Toritto, MD
Close
Sort by
Journal Articles

Long-Term Carfilzomib for High-Risk Patients with Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies

Roberto Mina, MD, Alessandra Larocca, MD, Maria Teresa Petrucci, MD, Gianluca Gaidano, MD, Stelvio Ballanti, MD, Pellegrino Musto, MD, Massimo Offidani, MD, Paola Omedé, Giulia Benevolo, MD, Alessandra Malfitano, Piero Galieni, MD, Michele Cavo, MD, Tommaso Caravita di Toritto, MD, Vittorio Del Fabro, MD, Vittorio Montefusco, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Sara Bringhen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3240.
https://doi.org/10.1182/blood-2018-99-112075
Published: 2018
Journal Articles

Immunotherapy in Multiple Myeloma: Experience of the Multiple Myeloma Gimema Lazio Group

Federico Vozella, MD, Agostina Siniscalchi, MD, Manuela Rizzo, MD, Tommaso Za, MD, Giusy Antolino, MD, Ugo Coppetelli, MD, Alfonso Piciocchi, Alessandro Andriani, MD, Ombretta Annibali, MD, Luca De Rosa, Giuseppe Cimino, Giacinto La Verde, Valerio De Stefano, MD, Maria Cantonetti, MD, Tommaso Caravita di Toritto, MD, Robin Foà, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5634.
https://doi.org/10.1182/blood-2018-99-115463
Published: 2018
Journal Articles

Once Weekly Versus Twice Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Pooled Analysis of Two Phase 1/2 Studies

Sara Bringhen, MD, Roberto Mina, MD, Maria Teresa Petrucci, MD, Lorenzo De Paoli, MD, Stelvio Ballanti, MD, Pellegrino Musto, MD, Massimo Offidani, MD, Stefano Spada, Giulia Benevolo, MD, Elena Ponticelli, Piero Galieni, MD, Michele Cavo, MD, Tommaso Caravita di Toritto, MD, Concetta Conticello, MD, Vittorio Montefusco, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Alessandra Larocca, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1990.
https://doi.org/10.1182/blood-2018-99-111252
Published: 2018
Journal Articles

Efficacy and Feasibility of Dose/Schedule-Adjusted Rd-R Vs. Continuous Rd in Elderly and Intermediate-Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients: RV-MM-PI-0752 Phase III Randomized Study

Alessandra Larocca, MD, Marco Salvini, MD, Lorenzo De Paoli, MD, Nicola Cascavilla, MD, Giulia Benevolo, MD, Monica Galli, MD, Vittorio Montefusco, MD, Tommaso Caravita di Toritto, MD, Anna Baraldi, MD, Stefano Spada, Nicola Giuliani, MD PhD, Chiara Pautasso, Stefano Pulini, MD, Sonia Ronconi, MD, Norbert Pescosta, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Claudia Cellini, MD, Patrizia Tosi, MD, Massimo Offidani, MD, Michele Cavo, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Sara Bringhen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 305.
https://doi.org/10.1182/blood-2018-99-111796
Published: 2018
Journal Articles

Double Autologous Stem Cell Transplantation Significantly Prolongs Progression-Free Survival and Overall Survival in Comparison with Single Autotransplantation in Newly Diagnosed Multiple Myeloma: An Analysis of Phase 3 EMN02/HO95 Study

Michele Cavo, MD, Francesca Maria Gay, Francesca Patriarca, MD, Elena Zamagni, MD, Vittorio Montefusco, MD, Luca Dozza, Monica Galli, MD PhD, Sara Bringhen, Nicoletta Testoni, BSc, Mariella Grasso, MD, Stelvio Ballanti, MD, Paola Tacchetti, MD, Giampietro Semenzato, MD, Anna Marina Liberati, Giulia Benevolo, Mauro Spriano, MD, Paolo Di Bartolomeo, MD, Tommaso Caravita di Toritto, MD, Angelo D. Palmas, MD, Anna Maria Cafro, MD, Fortunato Morabito, MD, Pellegrino Musto, MD, Rita Rizzi, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 401.
https://doi.org/10.1182/blood.V130.Suppl_1.401.401
Published: 2017
Journal Articles

Bortezomib-Dexamethasone Re-Treatment at Biochemical Relapse Vs Observation in Relapsed/Refractory Multiple Myeloma Patients: Results of a Phase II Multi-Center, Randomized Study

Roberto Mina, MD, Alessandra Larocca, Angelo Belotti, MD, Francesco Di Raimondo, MD, Anna Baraldi, MD, Massimo Offidani, MD, Monia Marchetti, MD, Roberto Ria, MD, Annarita Conconi, MD, Norbert Pescosta, MD, Mariella Grasso, MD, Giusy Cetani, MD, Anna Maria Cafro, MD, Roberto Passera, Rossella Troia, Gianpietro Semenzato, MD, Nicola Giuliani, MD PhD, Stelvio Ballanti, MD, Claudia Cellini, MD, Anna Marina Liberati, Tommaso Caravita di Toritto, MD, Maria Teresa Petrucci, MD, Pellegrino Musto, MD, Antonio Palumbo, MD, Pieter Sonneveld, MDPhD, Mario Boccadoro, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3128.
https://doi.org/10.1182/blood.V130.Suppl_1.3128.3128
Published: 2017
Journal Articles

An Integrated Analysis of Cardio-Vascular Adverse Events of Carfilzomib, Cyclophosphamide and Dexamethasone in Elderly Newly Diagnosed Myeloma Patients Enrolled in 3 Phase I/II Trials

Sara Bringhen, MD, Maria Teresa Petrucci, MD, Nicola Giuliani, MD, Angelo Michele Carella, MD, Mariella Genuardi, MD, Tommaso Caravita di Toritto, MD, Alessandra Malfitano, Pellegrino Musto, MD, Roberto Ria, MD, Giovannino Ciccone, MD PhD, Paola Omedé, Massimo Offidani, MD, Caterina Musolino, MD, Anna Marina Liberati, MD, Lorenzo De Paoli, MD, Stelvio Ballanti, MD, Piero Galieni, MD, Michele Cavo, MD, Concetta Conticello, MD, Roberto Foà, MD, Paolo Corradini, MD, Gianluca Gaidano, MD PhD, Antonio Palumbo, MD, Pieter Sonneveld, Mario Boccadoro, MD
Journal: Blood
Blood (2016) 128 (22): 3336.
https://doi.org/10.1182/blood.V128.22.3336.3336
Published: 2016
Journal Articles

Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study

Antonio Palumbo, MD, Federica Cavallo, MD, Izhar Hardan, MD, Barbara Lupo, MD, Valter Redoglia, PhD, Moshe Levin, MD, MS, Paolo Corradini, MD, Sara Pezzatti, MD, Francesca Patriarca, MD, Michele Cavo, MD, Magda Marcatti, MD, Norbert Pescosta, MD, Antonietta Pia Falcone, MD, Roberto Ria, MD, Davide Rossi, Giulia Benevolo, MD, Clotilde Cangialosi, MD, Monica Galli, MD, Lucio Catalano, MD, Anna Baraldi, MD, Angelo Michele Carella, MD, Annamaria Cafro, MD, Agostina Siniscalchi, MD, Claudia Crippa, MD, Sara Grammatico, MD, Maide Cavalli, Tommaso Caravita Di Toritto, MD, Francesco Di Raimondo, MD, Arnon Nagler, Mario Boccadoro, MD
Journal: Blood
Blood (2011) 118 (21): 3069.
https://doi.org/10.1182/blood.V118.21.3069.3069
Published: 2011
Journal Articles

Superior Complete Response Rate (CR) and Progression-Free Survival (PFS) with Bortezomib-Thalidomide-Dexamethasone (VTD) Versus Thalidomide-Dexamethasone (TD) As Consolidation Therapy After Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Michele Cavo, MD, Lucia Pantani, MD, Francesca Patriarca, MD, Maria Teresa Petrucci, Monica Galli, MD, Francesco Di Raimondo, MD, Giuseppe Rossi, MD, Antonio Palumbo, MD, Paola Tacchetti, MD, Massimo Offidani, MD, Vittorio Montefusco, MD, Franco Narni, MD, Tonino Spadano, MD, Claudia Cellini, MD, Norbert Pescosta, MD, Luca Baldini, MD, Antonio Ledda, MD, Tommaso Caravita Di Toritto, MD, Annalisa Pezzi, Statistician, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Filippo Gherlinzoni, MD, Maria Concetta Petti, MD, Daniele Derudas, MD, Stelvio Ballanti, MD, Valerio De Stefano, MD, Michele Baccarani, MD
Journal: Blood
Blood (2011) 118 (21): 1871.
https://doi.org/10.1182/blood.V118.21.1871.1871
Published: 2011